Halozyme Therapeutics Inc (NASDAQ:HALO)

Monday’s trading has closed, but HALO is being traded in the after-hours session. After-Hours quote »
22.80
Delayed Data
As of 3:59pm ET
 -0.44 / -1.89%
Today’s Change
7.51
Today|||52-Week Range
25.25
+136.27%
Year-to-Date

Today’s Trading

Previous close23.24
Today’s open23.13
Day’s range22.18 - 23.24
Volume1,314,177
Average volume (3 months)1,368,425
Market cap$3.0B
Dividend yield--
Data as of 3:59pm ET, 07/27/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+14.20%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book70.66

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+0.14+0.20%
RDUSRadius Health Inc-1.35-1.80%
NVAXNovavax Inc-0.17-1.44%
OPHTOphthotech Corp-0.98-1.45%
Data as of 3:59pm ET, 07/27/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers